Norman C. Selby

Norman C. Selby, Lead Independent Director of Infinity, has spent over 35 years in the healthcare world in a variety of consulting, managerial, investor, and Board roles. His primary activities today are centered on Real Endpoints LLC, an information and analytics company he helped found that is focused on the changing pharmaceutical reimbursement and market access landscape. He is also an advisor to two privately held digital health start-ups, Jasper Health, Inc. and Rhino HealthTech, and previously co-founded Paige.AI, an artificial intelligence company focused on computational pathology, where he was a board member from May 2017 to January 2020. Among earlier roles, Mr. Selby has served as the CEO of TransForm Pharmaceuticals, Inc., Executive Chairman of Windhover Information, Founder and Executive Chairman of Physicians Interactive Holdings, and as a board member of Millennium Pharmaceuticals.

Mr. Selby spent the bulk of his career at McKinsey & Company where he was Director (Senior Partner) in the firm’s New York office, and head of the firm’s Global Pharmaceuticals and Medical Products Practice. From 1987-1989, Mr. Selby took a leave of absence from McKinsey to serve as Chief Operating Officer of the New York Blood Center, the largest community blood organization in the country, where he led its financial and operational turnaround.